US Food and Drug Administration–Approved Gadolinium-Based Contrast Agents14-18
| Generic Name | Brand Name | Date Approved | Chemical Structure | Indication |
|---|---|---|---|---|
| Gadopentetate dimeglumine | Magnevist | 6/2/1988 | Linear | Central nervous system, extracranial/extraspinal, body |
| Gadoteridol | ProHance | 11/16/1992 | Macrocyclic | Central nervous system, extracranial/extraspinal |
| Gadoversetamide | OptiMARK | 12/8/1999 | Linear | Central nervous system, liver |
| Gadobenate dimeglumine | MultiHance | 11/23/2004 | Linear | Central nervous system, renal or aortoiliofemoral occlusive vascular disease |
| Gadodiamide | Omniscan | 9/5/2007 | Linear | Central nervous system, body |
| Gadoxetate disodium | Eovist | 7/3/2008 | Linear | Liver lesions |
| Gadofosveset trisodium | Ablavar (formerly Vasovist) | 12/22/2008 | Linear | Aortoiliac occlusive disease |
| Gadobutrol | Gadavist | 3/14/2011 | Macrocyclic | Central nervous system |
| Gadoterate meglumine | Dotarem | 3/20/2013 | Macrocyclic | Central nervous system |